Liu et al. [94] investigated the associations of serum levels of lactate dehydrogenase (LDH), ProGRP and NSE with clinical response and survival in SCLC patients receiving first-line platinum-based chemotherapy. Here, ENO2 is linked to small cell lung carcinoma.